Publications by authors named "Veronique Mary"

4Publications

SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy.

Authors:
Philippe Delay-Goyet Véronique Blanchard Nathalie Schussler Mati Lopez-Grancha Jean Ménager Véronique Mary Eric Sultan Armelle Buzy Jean-Claude Guillemot Jeanne Stemmelin Philippe Bertrand Thomas Rooney Laurent Pradier Pascal Barnéoud

Alzheimers Dement (N Y) 2016 Nov 3;2(4):267-280. Epub 2016 Nov 3.

Neurodegeneration and Pain Unit, Sanofi R&D, Chilly-Mazarin, France.

View Article and Find Full Text PDF
November 2016

Oxygen activation at the plasma membrane: relation between superoxide and hydroxyl radical production by isolated membranes.

Authors:
Eiri Heyno Véronique Mary Peter Schopfer Anja Krieger-Liszkay

Planta 2011 Jul 27;234(1):35-45. Epub 2011 Feb 27.

Commissariat à l'Energie Atomique (CEA Saclay), iBiTec-S, CNRS URA 2096, Service de Bioénergétique Biologie Structurale et Mécanisme, Bât. 532, 91191 Gif-sur-Yvette, France.

View Article and Find Full Text PDF
July 2011

Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.

Authors:
Vladimir P Grinevich Sharon R Letchworth Kari A Lindenberger Jean Menager Veronique Mary Khalima A Sadieva Lori M Buhlman Georg Andrees Bohme Laurent Pradier Jesus Benavides Ronald J Lukas Merouane Bencherif

J Pharmacol Exp Ther 2005 Feb 8;312(2):619-26. Epub 2004 Sep 8.

Targacept, Inc., 200 East First Street, Suite 300, Winston-Salem, NC 27101, USA.

View Article and Find Full Text PDF
February 2005

Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.

Authors:
Jean-Marie Stutzmann Veronique Mary Florence Wahl Odile Grosjean-Piot André Uzan Jeremy Pratt

CNS Drug Rev 2002 ;8(1):1-30

Aventis Pharma, Neurodegenerative Disease Group, 13, Quai Jules Guesde, 94400 Vitry-sur-Seine, France.

View Article and Find Full Text PDF
August 2002